Binx Health vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Binx Health develops FDA-cleared point-of-care molecular diagnostic platforms delivering chlamydia and gonorrhea results in 30 minutes at doctors offices; raised $280M total including $65M Series F in 2024; backed by EQT and OrbiMed.
About
Binx Health is a molecular diagnostics company founded in 2012 and headquartered in Boston, Massachusetts. The company develops point-of-care (POC) molecular testing platforms designed to bring lab-quality STI diagnostics to clinical settings outside traditional centralized laboratories — including physicians'' offices, urgent care clinics, pharmacies, and hospital emergency departments. Binx''s flagship platform, the binx io system, is FDA-cleared and CLIA-waived, enabling non-laboratory staff to perform certified molecular tests for chlamydia and gonorrhea with results delivered in approximately 30 minutes. CLIA-waiver status is critical because it allows the system to be operated in any point-of-care setting without requiring a laboratory director.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.